Inventor · disambiguated record
Philippe Guedat
Also filed as: GUEDAT PHILIPPE
15 granted patents·11 pending applications·35 citations·filing 2000–2023
89Inventor score
Top patents by PatentIndex Score
26 records- 0184US9682943B2Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseasesMEDICAL RES COUNCIL·Filed 2014·Granted Jun 20, 2017·6 cites·13 claims
- 0280US10526297B2Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseasesRES & INNOVATION UK·Filed 2018·Granted Jan 7, 2020·2 cites·24 claims
- 0379US10100020B2Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseasesMEDICAL RES COUNCIL·Filed 2017·Granted Oct 16, 2018·2 cites·20 claims
- 0479US7462615B2Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applicationsHYBRIGENICS SA·Filed 2005·Granted Dec 9, 2008·5 cites·9 claims
- 0574US6835712B1CompoundsSMITHKLINE BEECHAM PLC·Filed 2000·Granted Dec 28, 2004·10 cites·20 claims
- 0671US7767819B2Thiazolylimidazole derivatives and their use as inhibitors of microsomal triglyceride transfer proteinMERCK PATENT GMBH·Filed 2005·Granted Aug 3, 2010·2 cites·3 claims
- 0770US10954198B2Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseasesRES & INNOVATION UK·Filed 2019·Granted Mar 23, 2021·0 cites·22 claims
- 0868US7875613B2Tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applicationsHYBRIGENICS SA·Filed 2006·Granted Jan 25, 2011·1 cites·10 claims
- 0966US7674803B2Thiazolypiperidine derivatives as MTP inhibitorsMERCK PATENT GMBH·Filed 2004·Granted Mar 9, 2010·6 cites·20 claims
- 1059US8648076B2Cysteine protease inhibitors and their therapeutic applicationsGUEDAT PHILIPPE·Filed 2006·Granted Feb 11, 2014·1 cites·20 claims
- 1155US2005089493A1Novel compoundsUNIV CAMBRIDGE TECH·Filed 2004·Application pending·0 cites
- 1253US11084783B2O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteinsINFLECTIS BIOSCIENCE·Filed 2019·Granted Aug 10, 2021·0 cites·11 claims
- 1353US2020289436A1Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathiesINFLECTIS BIOSCIENCE·Filed 2020·Application pending·0 cites
- 1449US2024293343A1Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applicationsINFLECTIS BIOSCIENCE·Filed 2023·Application pending·0 cites
- 1546US10709677B2Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathiesINFLECTIS BIOSCIENCE·Filed 2015·Granted Jul 14, 2020·0 cites·12 claims
- 1645US2010048575A1Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applicationsGUEDAT PHILIPPE·Filed 2007·Application pending·0 cites
- 1741US10544093B2O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteinsINFLECTIS BIOSCIENCE·Filed 2015·Granted Jan 28, 2020·0 cites·17 claims
- 1839US2007129433A1Diphenylamine derivativesLARDY CLAUDE·Filed 2004·Application pending·0 cites
- 1937US2004138139A1Novel compoundsFiled 2001·Application pending·0 cites
- 2034US7723358B2Aroyl-O-piperidine derivatives for the treatment of diabetes-related problemsMERCK PATENT GMBH·Filed 2005·Granted May 25, 2010·0 cites·28 claims
- 2134US2007032499A1Novel cysteine protease inhibitors and their therapeutic applicationsGUEDAT PHILIPPE·Filed 2005·Application pending·0 cites
- 2234US2009181972A1Novel Inhibitors of Cysteine Proteases, the Pharmaceutical Compositions Thereof and their Therapeutic ApplicationsGUEDAT PHILIPPE·Filed 2006·Application pending·0 cites
- 2332US2010137601A1Thiazolylimidazole derivatives an their use as inhibitors of microsomal triglyceride transfer proteinGUEDAT PHILIPPE·Filed 2010·Application pending·0 cites
- 2429US2012128630A11-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharamaceutical composition thereof and their therapeutic useBERECIBAR AMAYA·Filed 2010·Application pending·0 cites
- 2527US10675257B2Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agentINFLECTIS BIOSCIENCE·Filed 2016·Granted Jun 9, 2020·0 cites·13 claims
- 2625US2012189579A1Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic useBERECIBAR AMAYA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Philippe Guedat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →